Received Oct 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | — | — |
Vaccine stored outside recommended conditions and administered to patient; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a 15-year-old male patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis. On 22-SEP-2025, the patient received Menveo. On an unknown date, an unknown time after receiving Menveo, the patient experienced incorrect storage of drug (Verbatim: Vaccine stored outside recommended conditions and administered to patient). The outcome of the incorrect storage of drug was not applicable. Additional Information: GSK Receipt Date: 26-SEP-2025 The medical assistant reported that they administered a Menveo 1 vial presentation to a patient after an excursion with the temperature, 11.10 degree Celsius for 168 hours. The excursion started on 19-SEP-2025 and Menveo 1 vial presentation was administered on 22-SEP-2025. The batch number was not provided upon follow up with the reporter.